| pubmed-article:15673542 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15673542 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:15673542 | lifeskim:mentions | umls-concept:C0027051 | lld:lifeskim |
| pubmed-article:15673542 | lifeskim:mentions | umls-concept:C2698872 | lld:lifeskim |
| pubmed-article:15673542 | lifeskim:mentions | umls-concept:C0520886 | lld:lifeskim |
| pubmed-article:15673542 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:15673542 | lifeskim:mentions | umls-concept:C0679199 | lld:lifeskim |
| pubmed-article:15673542 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:15673542 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:15673542 | pubmed:dateCreated | 2005-2-16 | lld:pubmed |
| pubmed-article:15673542 | pubmed:abstractText | Prior studies suggest that acute coronary syndromes (ACSs) are associated with endothelial activation and that this is of prognostic significance. We hypothesized that endothelial activation, as measured by a rise in von Willebrand Factor (DeltavWF), was influenced by the thrombolysis in myocardial infarction flow grade (TFG), the corrected TIMI frame count (CTFC) and the choice of anticoagulant therapy after fibrinolysis in ST elevation myocardial infarction (STEMI). | lld:pubmed |
| pubmed-article:15673542 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15673542 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15673542 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15673542 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15673542 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15673542 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15673542 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15673542 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15673542 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15673542 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:15673542 | pubmed:issn | 0195-668X | lld:pubmed |
| pubmed-article:15673542 | pubmed:author | pubmed-author:AntmanElliott... | lld:pubmed |
| pubmed-article:15673542 | pubmed:author | pubmed-author:GibsonC... | lld:pubmed |
| pubmed-article:15673542 | pubmed:author | pubmed-author:BraunwaldEuge... | lld:pubmed |
| pubmed-article:15673542 | pubmed:author | pubmed-author:MorrowDavid... | lld:pubmed |
| pubmed-article:15673542 | pubmed:author | pubmed-author:RayKausik KKK | lld:pubmed |
| pubmed-article:15673542 | pubmed:author | pubmed-author:MurphySabinaS | lld:pubmed |
| pubmed-article:15673542 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15673542 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:15673542 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15673542 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15673542 | pubmed:pagination | 440-6 | lld:pubmed |
| pubmed-article:15673542 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15673542 | pubmed:meshHeading | pubmed-meshheading:15673542... | lld:pubmed |
| pubmed-article:15673542 | pubmed:meshHeading | pubmed-meshheading:15673542... | lld:pubmed |
| pubmed-article:15673542 | pubmed:meshHeading | pubmed-meshheading:15673542... | lld:pubmed |
| pubmed-article:15673542 | pubmed:meshHeading | pubmed-meshheading:15673542... | lld:pubmed |
| pubmed-article:15673542 | pubmed:meshHeading | pubmed-meshheading:15673542... | lld:pubmed |
| pubmed-article:15673542 | pubmed:meshHeading | pubmed-meshheading:15673542... | lld:pubmed |
| pubmed-article:15673542 | pubmed:meshHeading | pubmed-meshheading:15673542... | lld:pubmed |
| pubmed-article:15673542 | pubmed:meshHeading | pubmed-meshheading:15673542... | lld:pubmed |
| pubmed-article:15673542 | pubmed:meshHeading | pubmed-meshheading:15673542... | lld:pubmed |
| pubmed-article:15673542 | pubmed:meshHeading | pubmed-meshheading:15673542... | lld:pubmed |
| pubmed-article:15673542 | pubmed:meshHeading | pubmed-meshheading:15673542... | lld:pubmed |
| pubmed-article:15673542 | pubmed:meshHeading | pubmed-meshheading:15673542... | lld:pubmed |
| pubmed-article:15673542 | pubmed:meshHeading | pubmed-meshheading:15673542... | lld:pubmed |
| pubmed-article:15673542 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15673542 | pubmed:articleTitle | Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy. | lld:pubmed |
| pubmed-article:15673542 | pubmed:affiliation | TIMI Study Group and Cardiovascular Division, Department of Medicine, Brigham & Women's Hospital/Harvard Medical School, Boston, MA, USA. kkray@partners.org | lld:pubmed |
| pubmed-article:15673542 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15673542 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15673542 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:15673542 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15673542 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15673542 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15673542 | lld:pubmed |
